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Diversity of the design and alignment of illumination and ultrasonic transducers empower the fine scalability and
versatility of optoacoustic imaging. In this study, we implement an innovative high-resolution optoacoustic
mesoscopy for imaging the vasculature and tissue oxygenation within subcutaneous and orthotopic cancerous
implants of mice in vivo through acquisition of tomographic projections over 180° at a central frequency of 24
MHz. High-resolution volumetric imaging was combined with multispectral functional measurements to resolve
the exquisite inner structure and vascularization of the entire tumor mass using endogenous and exogenous
optoacoustic contrast. Evidence is presented for constitutive hypoxemia within the carcinogenic tissue through
analysis of the hemoglobin absorption spectra and distribution. Morphometric readouts obtained with
optoacoustic mesoscopy have been verified with high-resolution ultramicroscopic studies. The findings described
herein greatly extend the applications of optoacoustic mesoscopy toward structural and multispectral functional
measurements of the vascularization and hemodynamics within solid tumors in vivo and are of major relevance to
basic and preclinical oncological studies in small animal models.
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Angiogenesis is a principal hallmark of malignant tumors and has
been implicated as a therapeutic target [1,2]. In the course of
carcinogenesis, nascent vessels feeding growing tumors have been
reported to become irregular, acquire tortuous shape, and develop
profuse system of anastomoses, resulting in atypical vascularization of
the tissue mass with focal hypoxia and occasional bleeding [3,4].
Hence, imaging of the vasculature and hemoglobin gradients in
tumors can reveal its malignant features, facilitating better under-
standing of the biology of their blood supply and pathobiology of
angiogenesis [5]. The gold standard for studying the angiogenesis and
disease-related vascular aberrations is set by histological examinationl
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branching within the tissue mass, yielding important diagnostic and
prognostics data [6]. While specific and highly informative, this
method requires biopsy, which not only is susceptible to sampling
errors but has limited applications for serial monitoring of tumors [5].
It is also laborious, costly, and offers limited [two-dimensional (2D)]
views to the tumors. Thus, there is pressing need in developing
cutting-edge technologies for intravital imaging of tumors, which
would surpass mentioned methodological limitations and yield
three-dimensional (3D) data with precise anatomical registration.
Over the years, X-ray computed tomography and magnetic
resonance imaging were applied for vascular imaging in vivo and have
partly overcome the limitations of the histological method, albeit at
higher costs, with lower specificity and occasional inconclusive data and
risks of exposure to ionizing radiation or paramagnetic contrast agents
[7–9]. Noteworthy, quantification of tumor vascularization using
magnetic resonance imaging is also technically challenging, especially
for larger vessels, due to poor correlation between magnetic signal and
contrast agent concentration as well as erroneous focal enhancement of
the signal related to accumulation of the latter [9]. High-resolution
optical imaging modalities such as confocal and multiphoton imaging
have also been implemented for intravital molecular and functional
imaging [10]. The limited field of view along with poor penetration
(b2mm and b 500 μm, respectively) however renders these inadequate
for deep tissue imaging with volumetric measurements of large solid
tumors. Recently, multispectral fluorescence ultramicroscopy has been
applied for 3D optical sectioning of vascular networks in tumor models,
attaining an impressive (6 μm) in-plane resolution, with strong light
scattering within the tissue however greatly hampering its in vivo
applications [11].
Optoacoustic (OA) imaging is an emerging modality of hybrid
imaging which utilizes for image production ultrasonic waves
generated in response to optical absorption within the tissue exposed
to short laser pulses. The capability to resolve the blend and spectra of
endogenous and exogenous optical contrast at ultrasonic resolutions
has endowed OA imaging the ability to deliver high-resolution
readouts from depths not accessible to any other modality of optical
microscopy, with tremendous potential for 3D imaging of solid
tumors and their vascularization [12–15]. Through combination of
single wavelength excitation and raster scanning, OA imaging has
been used for visualization of angiogenesis in carcinogenic tissue
[16–18]. Optical interferometry with raster scanning at single
wavelength excitation has also been applied for monitoring the
growth of tumors and their response to therapeutic interventions
[19]. Although advantageous, under both arrangements, a single
element detector is raster scanned over the area of interest, with
hardware limitations imposing major restrictions on multiwavelength
excitation and volumetric measurements at high temporal resolution.
With implementation of the imaging frequency bandwidth, recently,
high-resolution imaging at depths of 2 to 7 mm has been achieved
with multispectral optoacoustic mesoscopy (MSOM). We have
shown the unique capability of a translate-rotate OA scanner with
linear transducer arrays for generating volumetric data sets at
mesoscopic scale in acutely excised samples [20] at spatial resolution
of ~30 μm [21]. The capabilities of this arrangement for 3D volumetric
imaging of biological specimens in vivo remained to be explored.
Using an innovative arrangement suited for the interrogation of
living animals, we implement a translate-rotate scanner for
multispectral 3D intravital imaging of the vasculature and hemody-namics of cancerous tumor at a frequency bandwidth of ~2 to
40 MHz. We apply MSOM in vivo for volumetric measurements of
tumor vasculature and showcase high-isotropic-resolution imaging of
the entire tumor mass under unperturbed conditions based on endo-
and exogenous gold nanoparticles. Finally, we interrogate the
distribution of hemoglobin gradients, which suggest constitutive
hypoxemia within the tumor core. The findings with MSOM have
been confirmed with histology and ultramicroscopic studies of
tumors ex vivo. The possibility of the future use of MSOM for cancer
research is discussed.
Materials and Methods
Experimental Setup and Data Acquisition
Figure 1, A and B illustrates the experimental setup. Ultrasonic
detection was performed using a high-frequency 128-element linear
array (Vermon, Tour, France) with a 24-MHz central frequency and
an average −6 dB two-way bandwidth of 60%. The transducer
elements had a 70-μm pitch and were cylindrically focused through
an acoustic lens at ~7.5-mm distance. The recorded signals were
digitized by a custom-built data acquisition card (125 M samples/s
and 12-bit resolution over a 16-mV range). The linear array was
mounted on two motorized stages: a high-accuracy translation stage
and a precision rotation stage (M-605.2DD and M-062.PD,
respectively, Physik Inst., Karlsruhe, Germany), enabling precise
positioning of the transducer and recording of its location
(Figure 1A). The array was mounted on a custom-made holder,
introducing a 45-angular-degree tilt along the elevation dimension.
The latter enabled an access for the transducer to the sample under
investigation and detection of waves generated by a multitude of
absorbers with different orientations, replicating the muddled tumor
environment. A custom-made animal holder was designed for
mounting the experimental animal. The excitation beam was guided
by a 640-fiber bundle partitioned in four arms (Figure 1B). The latter
were positioned on an arc 1 cm away and oriented toward the sample,
enabling optical excitation in a volume of 1 cm3, optimal for tumor
imaging under our settings. Near-infrared excitation light was sourced
from a tunable (690-900 nm) optical parametric oscillator laser
(OPOTEK, Carlsbad, CA) as nanosecond-long pulses with a 10-Hz
repetition rate. The scanning routine used by the OA imaging system
was based on the translate-rotate continuous implementation
reported previously [18], which was chosen to ensure homogeneous
in-plane resolution with good sensitivity to absorbers at all
orientations. The linear array was continuously rotated 172° around
the sample at a predefined speed, which was selected based on the
repetition rate of the pulsed laser. For each laser shot, a trail of
recording was transferred to the data acquisition system (DAQ) and
digitized. The radius of the transducer’s middle element (64) was set
at 6.3 mm and corresponded with the middle plane of the
experimental specimen. For tumor visualization, animals were placed
on the bed holder, exposing the tumor mass regions through an
aperture of the holder and enabling its direct contact with preheated
water used as an acoustic coupling medium (Figure 1B).Phantom and Animal Preparations
System characterization was performed on three turbid phantoms
made of 1.6% agar and 0.8% intralipid (Sigma Aldrich, Germany),
which were molded to form a cylindrical shape, in a 5-ml syringe
(Figure 2). The molds measured 11 mm in diameter and 2 cm in
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Figure 1. An overview of the experimental setup and data simulation. (A) Experimental setup: linear array mounted on a high-precision
translation stage, attached to a rotation platform. The transducer is connected to a specially designed holder, tilting the length axis to 45
angular degrees, providing access to the sample under investigation. RS, rotation stage; TS, translation stage; AP, adapting plate; LR,
linear array. (B) Schematic of the implantation sites of tumors in a mouse (top) with a view of the mouse holder (MH) and the four fiber
bundles (FB) delivering the illumination to the tumor (Tu) (bottom). Arrow with dashed line indicates the rotation trajectory of the linear
array, while red arrowheads depict the translation motion. (C) Simulated results of 10-μmmicrospheres with different tilting angles of the
transducer (0°, 30°, and 45°): an aerial view (xy plane) and side view (xz plane). (D) Graphical representation of the relationship between the
encompassed volume of the sample and angular tilting of the array (blue dashed curve) and standard deviation of the 3D resolution (black
curve). (E, F) Simulated configuration of a center absorber (suture; 100-μmdiameter) with the first (red) and last (blue) detector positions in
a tomographic scan varying the angular tilting of the transducer with reconstructed images along the xz plane depicting the absorber for
0°, 30°, and 45° tilting of the array. AS, absorbing suture; S, starting; E, ending degrees.
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polyamide suture (Vetsuture, Paris, France) arranged in a single
1-cm–long knot, which was placed vertically in the embedding
medium to mimic an absorbing sample with a complex shape of
different absorber orientations. Phantom 2 contained 9 microspheres
(D = 200 μm; Cospheric LLC, Santa, Barbara, CA) arranged to form
a “plus” shape along the entire diameter of the embedding medium
(1 cm) and was used to characterize the in-plane field of view of the0 0.1 0.2 0.3 0.5 0.6 0.7 0.80.4(mm)
35 µm
y
z y
x
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Aerial VA B
Figure 2. Characterization of the performance of the MSOM in phanto
suture—maximum intensity projection (MIP) side view (left) and aerial
30-μm suture. (B) Phantom 2 (left inset, an overview): 9 microspheres
mold—MIP aerial view. (C) Phantom 3: 10-μm microspheres—MIP;
magnification. Scale bar: 1 cm.system. Phantom 3 was made of 10-μm microspheres (Polybead
Microspheres; Polysciences, Inc., Warrington, PA) diluted in agar and
spread across a 1-cm3 area to provide a reference for computing the
resolution of the system with respect to isotropic absorbers generating
broadband frequencies.
The in vivo experiments were performed on 8-week-old
athymic nude-Foxn1 female mice (Harlan, Germany) implanted
subcutaneously or orthotopic with 4T1 carcinoma (breast tumory
x
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Aerial View Side View
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x
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z
C
ms. (A) Phantom 1 (left inset, an overview): OA view of 30-μm knot
view (right, top). Inset (yellow) represents an intensity profile of the
(200-μmdiameter each) scattered over the surface of the cylindrical
aerial and side views. Boxed: microspheres presented at higher
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suspensions in the dorsal upper pelvis (1 million 4T1), while the
second (mouse 2) received orthotopic implant into the mammary pad
(0.5 million 4T1 cells) (CRL-2539). Imaging procedures were
performed under general anesthesia (1.8% isoflurane with 100% O2)
and have been approved by the Government of Upper Bavaria (N
55.2.1.54-2632-102-11). Cells were authenticated by the ACTT
postfreeze viability, morphology, mycoplasma contamination, growth,
and interspecies determination tests as well as bacterial and fungal
contamination, with all tests proven to be negative. Imaging was started
after tumors reached ~1 cm3; mouse 1 was imaged 10 days after
inoculation with single wavelength optical excitation, while mouse 2 was
imaged 11 days after tumor inoculation and 1 hour after intravenal
injection of gold nanoparticles (50 μl of gold nanoparticles, equivalent to
6e10 particles/μl). For spectral imaging, multispectral acquisitions between
720 and 815 nm were performed. The averaged laser power was tested
before each scan with a power meter FieldMaxII-Top (Coherent, Santa
Clara, CA) to correct for its fluctuations in the course of experiment.
Histochemical Staining of Cancerous Tissue and
Ultramicroscopic Analysis
Histochemical staining and ultramicroscopic analysis have been
implemented for postmortem validation of the cancerous tissue
ex vivo, with experimental procedures and results detailed in the
Supplementary Methods and Results.
Data Processing and Analysis
Noise filtering was performed off-line based on the transducer
specifications. Signals were band-pass (2-40 MHz) filtered with
Butterworth (order 3). A wavelet decomposition (db2) with two levels
of discrimination was performed on filtered signals to separate the
data into low- and high-frequency components. The two decomposed
levels were separately reconstructed using a 3D filtered
back-projection algorithm [19]. The reconstructed volumetric data
sets were loaded in Amira (FEI, Visualization Sciences Group,
Germany) with visualization angles selected for volumetric rendering
and illustration purpose. The two wavelet-decomposed images were
superimposed using ImageJ. Spectral unmixing was applied to detect
the presence of oxygenated or deoxygenated hemoglobin or injected
contrast agent. Before unmixing, multispectral images were corrected
for wavelength-dependent fluctuations of the laser power. For each
reconstructed voxel, the absorbed spectrum within this voxel was fitted
linearly with that of the expected components present in the sample.
Four known spectra corresponding to deoxy- and oxyhemoglobin
(HbO2 and Hb), the injected nanorods, and a constant spectrum were
used for unmixing process and background normalization.
Results
Design and Conceptual Validation of the Experimental Setup
To achieve in vivo volumetric visualization of solid tumors, a new
imaging principle has been implemented based on the previously
reported translate-rotate detection geometry [21]. Advantage has been
taken from optimizing imaging perspective of the linear array scanner,
generating a conical detection surface, which enabled application of
MSOM for imaging of solid tumors in vivo (Figure 1, A and B). The
operational capabilities of the system have been assessed using
analytical simulations of 10-μm absorber placed in the center of the
coordinate system. An incremental inclination angle was used in order
to compute 91 reconstructed volumes. Figure 1C presents resultsgained from simulated absorber at three different angular tilting
values. Although changes in the angle of the transducer array did not
visibly alter the in-plane xy resolution, improvements have been
achieved in z dimension. Indeed, in conical configuration of imaging,
the elongation of the absorber (Figure 1C) along the vertical axis is
notably reduced compared to the cylindrical implementation
(“rice-grain” aspect in xz plane 0° tilting of the array). Figure 1D
depicts a plot (black line) of the standard deviation of the resolution
values along the x, y, and z dimensions for the simulated absorber at
all 91 angular positions. As can be seen, at 45° inclination, the
standard deviation is relatively reduced (~25 μm), implying an
isotropic resolution. Moreover, by calculating the volumetric aperture
of the system, the sampling volume was measured to be 6.34 mm in
height (blue dotted line). A further assessment of the sampling
volume by tilting the angle of the transducer has confirmed the
predicted reduction of the vertical aperture of the system (Figure 1, E
and F). Using an absorbing suture (100 μm in diameter), a clear
decrease in vertical field of view has been also verified with such
an arrangement.
Characterization of the Performance of MSOM System
The volumetric capabilities of the MSOM system for visualization
of multiple orientations of the specimen were characterized using
phantom 1, with results presented in Figure 2A. The composite shape
of a 30-μm–diameter single-looped knot of the suture provides a
model multifaceted structure, which was imaged and serially
reconstructed over the entire volume, scaling 9 mm in height and
10 × 10 mm along xy planes. The aerial view of maximum intensity
projection (MIP) of the reconstructed volume shows the circular
pattern of the single-looped knot. As evident, the reconstructed
volume does not reveal any elongations along any axis, implying
resolution homogeneity of the entire field of view. To confirm that
3D reconstructed images can be quantified, an intensity profile across
one side of the suture was computed and full width at half maximum
was defined (Figure 2A). To evaluate the imaging field of view of
MSOM, phantom 2 comprised of 9 microspheres of 200 μm in
diameter was scanned. The microspheres were arranged to form a
“plus” sign along the surface of the phantom (Materials and
Methods). Figure 2B represents the reconstructed MIP along the z
axis. As evident, the microspheres can be clearly resolved along the
entire diameter of the sample, with dust particles also visible on the
lower part of the reconstructed volume. Likewise, phantom 3
comprised of microspheres of 10 μm diameter and randomly
scattered within the content of the agar was imaged to determine
the resolution of the system with respect to isotropic objects. Three
microspheres located at different depths and random in-plane
positions were selected for full width at half maximum computation
based on their intensity profile (Figure 2C). The estimated resolution
derived from these measurements is close to 70 μm along all tested
dimensions. Collectively, these data are in agreement with previous
OA measurements with the use of the same transducer and confirm
that the MSOM system achieves an isotropic resolution along the x,
y, and z dimensions and thus is suitable for volumetric imaging of
biological samples.
Volumetric Imaging of the Vasculature of Cancerous Tissue InVivo
A subcutaneous 4T1 tumor model was selected for imaging the
vasculature inside the cancerous tissue mass, based on the intrinsic
optical contrast, on day 10 postinoculation (mouse 1) in vivo.
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diameter) in the dorsal upper pelvis prior to OA imaging. The
apparent hyperemia with rubor indicates local immune response with
intense metabolism of proliferating tissue. The OA view of the tissue
mass reveals its profuse vascularization with dense network of vessels
of varying diameters, as coded with color (Figure 3C). Of note, the
microvessels appear to concentrate at the periphery, while the larger
vessels with profuse anastomoses feed the deeper compartments of the
cancerous tissue mass. To obtain a volumetric view of the tumor,
volume-rendered 3D single-wavelength (760 nm) images were
acquired and reconstructed with Amira. Assessments of the diameter
of the randomly selected vessels on the maximal area projection
revealed a range of diameters varying between 70 μm and 250 μm,
with microvessels clearly distinguishable on the surface as well as deep
inside of the tumor. Optoacoustic 2D cross-sectioning of the tissue
mass revealed asymmetric distribution of the vasculature, with
prevalence of dense networks of anastomosis at the base of the tumor,
while the core and apex receive a more refined system of blood supply
(Figure 3, E–G). To evaluate the utility of MSOM for fine vascularA
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Figure 3. Label-free intravital imaging of the tumor vasculature of su
mouse model (mouse 1; day 11 postinoculation). (B) Higher-magnific
with dashed line. (C) MSOM image representing MIP of the entire
with highlighted three (1-3) cross sections (D) and planar view of
(E). Visualization of three 2D vertical (z) positions selected from top, m
vascular network and branching within the core of the tumor and atmorphometry and assessment of the vessel diameter and branching,
two regions of interest were visualized at higher magnification
(Figure 3, F and G). As evident, this approach enables measurements
of the vessel diameter on randomly defined segments along with
intensity profile and confirms the applicability of intravital MSOM
imaging for resolving both large vessels and microvasculature within
tumors, essential for studies of the biology and pathobiology of
vascularization of the solid tumor tissue. Thus, based on the
endogenous contrast, profuse vascularization of the tissue mass with
large and small vessels can be volumetrically visualized and analyzed.
Importantly, as shown in Figure 3, both 2D and 3D projections can
be selected for closer examination of the vascular elements of the
tumor to reveal greater morphological details at different depths of the
tissue mass.
Application of MSOM for Nanoparticle and
Functional Imaging of Tumors
To confirm the utility of MSOM as a versatile tool for volumetric
imaging of solid tumors with endo- and exogenous contrast as well asAerial View
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bcutaneous 4T1 tumor with MSOM. (A) Color photograph of the
ation photograph of the tumor site: the body of the tumor marked
tumor: aerial view. (D, E) Volume-rendered image of the tumor
individual planes corresponding to different depths of imaging
iddle, and bottom of the tumor mass. (F, G) Magnified view of the
the periphery. Scale bar: 1 cm.
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the mammary pad of a mouse (mouse 2) was scanned on day 11
postinoculation. Gold nanoparticles were used as an exogenous
contrast, while O2-related spectral changes in the hemoglobin
absorbance were taken as indicative of the oxygenation levels across
the cancerous mass. Figure 4, A and C illustrates an overview of the
orthotopic 4T1 tumor with MSOM image of the reconstructed
vasculature. Similar to the subcutaneous tumor (mouse 1), the
mammary implant measured ~9 mm in diameter and revealed signs
of local inflammation and enhanced metabolic activity with profuse
system of vascularization (Figure 4A). Spectral comparison of the
hemoglobin saturation across the tumor mass revealed markedly lowerA
C
E
D
Figure 4. Structural, functional, and molecular MSOM of a 4T1 ortho
4T1 orthotopic tumor (side view) with color photograph of the mouse
the absorption spectra of the extrinsic agent (gold nanoparticles
respectively). (C) Optoacoustic aerial view of the tumor (from A) and (D
the core of the tumor: an aerial view. Double white arrows highlight
in-boxed region (C) with vascular labeling using gold nanorods (yell
tagging with Lectin-InvivoTag 750. White arrows point to aggrega
Figure 5A). Scale bar: 1 cm.oxygenation within the tumor core, in line with previous reports
[22,23] (Figure 4D). Imaging of the tumor 1 hour after intravenous
injection of gold nanoparticles demonstrates exquisite labeling with
strong contrast of the vasculature and their ready transfusion
throughout the entire tumor volume, including its core (Figure 4E).
To verify revealed by MSOM histologically abnormalities of the
morphology of tumor vascularization, postmortem ultramicroscopy
and histochemical assessments have been carried out. After MSOM
imaging, under deep anesthesia, mouse was injected with
Lectin-InvivoTag 750 (2 nmol/0.5 ml, i.v.) and killed with ketamine
overdose (120 mg/kg). Tumor was excised, processed for ultramicro-
scopy with hematoxylin and eosin staining, and imaged. DistinctF
B
topic (mouse 2; day 11) tumor in vivo. (A) Optoacoustic image of a
with mammary implant (inset, left). (B) Graphical representation of
, AuNR) and of the oxy- and deoxyhemoglobin (Hb and HbO2,
) color-coded images of the distribution of the HbO2 and Hb within
differential distribution of the HbO2 and Hb. (E) Magnified view of
ow). (F) 3D MIP projections of ultramicroscopy showing vascular
tes of fibrin with necrotic tumor cells within the core (see also
Neoplasia Vol. 18, No. 8, 2016 High-Resolution Multispectral OA Tomography Chekkoury et al. 465labeling of the vasculature with Lectin-InvivoTag 750 is clearly visible
through the red channel, while autofluorescence marking the stroma
and contours of the tumor is visible in green (Figures 4F and 5, B
and C). Of note, Lectin-InvivoTag 750 staining of the core of the
tumor was sparse, suggestive of a deep necrotic process within the
tissue mass (Figure 4F). The later was confirmed also by histological
examination (Figure 5A). At this stage, however, we cannot rule out
the contribution of the poor penetration of Lectin-InvivoTag 750 into
the core of the tumor. Overall, these data confirm the applicability of
MSOM as a versatile tool for visualization and volumetric studies of solid
tumors in vivo, with readouts compatible to those obtained throughmore
invasive histochemical methods combined with microscopy.
Discussion
Understanding the mechanisms governing the angiogenesis and
vascularization of solid tumors in vivo is of major basic and
translational importance, with direct diagnostic and prognostic
implications [2–4]. Available means for angiography and imaging
the vascularization of tumors, while informative, also have major
limitations, demanding their further improvement with better
characterization. OA imaging emerges as a powerful bioimaging
modality and has been applied for basic and preclinical studies of
tumors and tumor-related angiogenesis in vivo [22,24–26]. These,
however, provided limited information of the exquisite morphology
and architecture of the vascularization and were specialized for
capturing general features of solid tumors [14]. To reveal a fuller
picture and gain better in-depth resolution, we have implemented
recently a raster scanning approach [17]. Improved spatial resolution
and image quality reported in this study, however, came with
restriction to a single wavelength optical excitation, lower data
acquisition rate, and limited access [16,18,19,27]. To gain spectral
information, optical interferometry with multiple wavelength
excitations has been implemented for imaging tumor growth and
treatment response over time [19,28]. We have recently applied a
spherical ultrasound detection array for real-time vascular imaging
with functional and structural capabilities, albeit with limited spatial
resolution and poor feature imagining capacities [29]. Taking theseA B
Figure 5. (A) 2D histological cross sections (Hematoxylin Eosin - H&E) o
(B) MIP view of ultramicroscopic reconstruction of the tumor: autoflu
presented at highermagnification in (C). Note the tortoise appearance ointo consideration, herein we introduce a novel translate-rotate
detector-based MSOM system for multispectral volumetric meso-
scopy of solid tumors with improved accessibility. A linear
high-frequency transducer has been combined with a flexible
arrangement of detectors to capture the entire tumor mass (1 cm3)
at a uniform spatial resolution of ~70 μm and improved feature
representation. Proof of principle is provided for the applicability of
high-resolution imaging toward tracking systemically applied contrast
as well as visualization of hemoglobin gradients, which are of prime
relevance to pharmacokinetics, drug penetration, and metabolic rate
studies. Overall, these advances extend the OA mesoscopy toward
improved lateral and axial resolutionwith volumetric imaging capabilities.
The performance of MSOM system has been tested in two models
of solid malignant tumors: subcutaneous and orthotopic implants,
followed by postmortem histochemical analysis. It is important to
note that, in addition to proving the general feasibility of the
volumetric mesoscopy of tumors, the orthotopic mammary implants
studied herein provide a realistic model for pre-clinical breast cancer
research [30]. Encouragingly, the overall topography and distribution
of the vasculature within the tumor mass revealed with MSOM are in
agreement with our histological data as well as with results of
ultramicroscopic analysis, demonstrating dense vascularization of the
stroma of the tumor with irregularly branching vessels of tortuous
shape and profuse anastomoses and lacunas, considered as hallmarks
of malignant cancers [31–33]. The latter are likely to contribute
toward irregular blood flow with low oxygenation levels in the core of
the growing tissue mass, along with signs of local immune response, as
evident from hyperemia seen in our models. Interestingly, reports
indicate that the nascent vascular system within solid tumors is
represented by endothelial cell tubes, which lack well-developed wall
structures and exhibit a limited capacity for blood flow with gas and
nutrient exchange [34–36]. These observations are in agreement with
preclinical and clinical data, showing a similar histopathological
profile in breast cancer models and human samples [37,38]. The
capability of MSOM to resolve the fine contrasts provided by
nanoparticle as well as map hemoglobin gradients [26,39,40] implies
its suitability as a tool for quantifying of hemodynamics and diffusionC
f a tumor corresponding to three planes selected at different depths.
orescence—green; lectin vascular labeling—red with inboxed area
f themajor vasculature within the core of the tumor. Scale bar: 1 cm.
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sensitivity, advocating its broad future applications.
From a technical point of view, by combining high-resolution
multispectral imaging with improved accessibility and enhanced data
acquisition rates, the technology presented herein makes a substantial
step forward compared to other optical intravital vascular imaging
modalities. The implemented flexible scanning geometry facilitates a
broad coverage angle with true volumetric recordings of the OA
signals generated deep within the tissue. This feature constitutes a
principal advantage over previously presented systems with a single
element detector with limited access to the sample and poor 3D
imaging capabilities. In regard to longitudinal studies, compared to
systems with only cross-sectional imaging capabilities, MSOM
described here offers full-view visualization of the entire sample,
eliminating the need in challenging histological procedure of
reproducing the same plane for imaging. A similar translate-rotate
platform was used earlier to extract anatomical and functional
information from excised samples, but due to the enclosed angle
imposed in cylindrical configuration, the sample under investigation
could not measure more than 12 mm [41]. By including an
inclination angle of the transducer along the long axis, in this study, a
conical detection surface has been generated, which enables a larger
interrogation field with an isotropic volumetric imaging. Implemen-
tation of the translate-rotate geometry as shown, thus, introduces an
optimal balance between the field of view necessary for intravital
imaging and 3D resolution performance, never reported previously.
From a detection point of view, the MSOM system presented herein
affords recordings in higher frequency ranges, gaining better
resolutions with higher tolerance to the depth-related corruption of
ultrasound signals. Finally and complementarily, the versatility of the
approach used herein enables imaging of wide ranges of configura-
tions with broader choice of research models.
Although at present the temporal resolution of MSOM is limited
by the repetition rate of the pulsed laser, research is currently under
way toward overcoming this constraint. Increased pulse repetition
would afford several benefits, including monitoring faster biological
and physiological processes. Improved spatial and temporal resolution
together with multispectral capabilities should also be beneficial for
future studies of vascularization and functional dynamics of tumors
and other neoplasia, facilitating the research and understanding of the
pathobiology of angiogenesis in murine tumor models, with
implication for oncology and oncotherapy.
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